JAMP TRAMADOL HCL DIN 02518759
Health Canada record
| Active ingredient(s) | TRAMADOL HYDROCHLORIDE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N02AX02 TRAMADOL |
| Original market date | 08-Feb-2023 |
| Current status date | 08-Feb-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRAMADOL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02477092 | AG-ACET-TRAMADOL | ANGITA PHARMA INC. | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Approved |
| 02426153 | APO-TRAMADOL | APOTEX INC | Tablet | TRAMADOL HYDROCHLORIDE 50 MG | Marketed |
| 02479672 | AURO-TRAMADOL | AURO PHARMA INC | Tablet | TRAMADOL HYDROCHLORIDE 50 MG | Marketed |
| 02439050 | AURO-TRAMADOL/ACETAMINOPHEN | AURO PHARMA INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02373017 | DURELA | CIPHER PHARMACEUTICALS INC | Capsule (Extended-Release) | TRAMADOL HYDROCHLORIDE 100 MG | Marketed |
| 02373033 | DURELA | CIPHER PHARMACEUTICALS INC | Capsule (Extended-Release) | TRAMADOL HYDROCHLORIDE 300 MG | Marketed |
| 02373025 | DURELA | CIPHER PHARMACEUTICALS INC | Capsule (Extended-Release) | TRAMADOL HYDROCHLORIDE 200 MG | Marketed |
| 02387123 | IPG-TRAMADOL/ACET | MARCAN PHARMACEUTICALS INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Approved |
| 02388308 | JAMP-ACET-TRAMADOL | JAMP PHARMA CORPORATION | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02480859 | MAR-TRAMADOL | MARCAN PHARMACEUTICALS INC | Tablet | TRAMADOL HYDROCHLORIDE 50 MG | Marketed |
| 02388324 | MAR-TRAMADOL/ACET | MARCAN PHARMACEUTICALS INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02389800 | MINT-TRAMADOL/ACET | MINT PHARMACEUTICALS INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02299216 | RALIVIA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 300 MG | Marketed |
| 02299194 | RALIVIA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 100 MG | Marketed |
| 02299208 | RALIVIA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 200 MG | Marketed |
| 02450429 | TARO-TRAMADOL ER | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 100 MG | Marketed |
| 02450437 | TARO-TRAMADOL ER | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 200 MG | Marketed |
| 02450445 | TARO-TRAMADOL ER | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 300 MG | Marketed |
| 02388197 | TARO-TRAMADOL/ACET | SUN PHARMA CANADA INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02347180 | TEVA-TRAMADOL/ACETAMINOPHEN | TEVA CANADA LIMITED | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Marketed |
| 02296381 | TRIDURAL | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 100 MG | Marketed |
| 02296403 | TRIDURAL | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 200 MG | Marketed |
| 02296411 | TRIDURAL | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 300 MG | Marketed |
| 02286432 | ZYTRAM XL | PURDUE PHARMA | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 200 MG | Marketed |
| 02360349 | ZYTRAM XL | PURDUE PHARMA | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 100 MG | Marketed |
| 02286459 | ZYTRAM XL | PURDUE PHARMA | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 400 MG | Marketed |
| 02360322 | ZYTRAM XL | PURDUE PHARMA | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 75 MG | Marketed |
| 02286424 | ZYTRAM XL | PURDUE PHARMA | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 150 MG | Marketed |
| 02286440 | ZYTRAM XL | PURDUE PHARMA | Tablet (Extended-Release) | TRAMADOL HYDROCHLORIDE 300 MG | Marketed |
| 02383209 | ACT TRAMADOL/ACET | ACTAVIS PHARMA COMPANY | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02477122 | BIO-TRAMADOL/ACET | BIOMED PHARMA | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Pre Market |
| 02507005 | JAMP TRAMADOL | JAMP PHARMA CORPORATION | Tablet | TRAMADOL HYDROCHLORIDE 50 MG | Dormant |
| 02407981 | LUPIN-TRAMADOL/ACET | LUPIN PHARMA CANADA LIMITED | Tablet | TRAMADOL HYDROCHLORIDE 37.50 MG; ACETAMINOPHEN 325.00 MG | Cancelled Pre Market |
| 02425599 | MYLAN-TRAMADOL/ACET | MYLAN PHARMACEUTICALS ULC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02469650 | NRA-TRAMADOL/ACET | NORA PHARMA INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02389274 | PAT-TRAMADOL/ACET | PATRIOT A DIVISION OF JANSSEN INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02401657 | PMS-TRAMADOL-ACET | PHARMASCIENCE INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Dormant |
| 02391554 | PRIVA-TRAMADOL/ACET | PHARMAPAR INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02424959 | RIVA-TRAMADOL/ACET | LABORATOIRE RIVA INC. | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02493764 | SANDOZ TRAMADOL | SANDOZ CANADA INCORPORATED | Tablet | TRAMADOL HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02264846 | TRAMACET | JANSSEN INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02429969 | TRAMADOL / ACETAMINOPHEN | SIVEM PHARMACEUTICALS ULC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02417502 | TRAMADOL-ACET | PRO DOC LIMITEE | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02426803 | TRAMADOL/ACET | SANIS HEALTH INC | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02388294 | TRAMAPHEN-ODAN | ODAN LABORATORIESLTD | Tablet | TRAMADOL HYDROCHLORIDE 37.5 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 02349469 | ULTRAM | JANSSEN INC | Tablet | TRAMADOL HYDROCHLORIDE 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 32692 | 2024-02-13 | Supplement to an Abbreviated New Drug Submission (SANDS) | Update to the Product Monograph. Update to Labels |
| 26371 | 2021-08-04 | Abbreviated New Drug Submission (ANDS) |
International API supply for TRAMADOL HYDROCHLORIDE
13 valid EDQM Certificates of Suitability from 13 holders. 18 active FDA Drug Master Files.
Request a quote for JAMP TRAMADOL HCL